Charchian Medical Corp is categorized under Chiropractors in Glendale, CA and active since 1985.
Charchian Medical Corp was established in 1985, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Chiropractors business, which does work in the B2C market, and is classified as a Chiropractors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Nora Aghkani, Office Manager at the company’s single location by writing to 1030 South Glendale Avenue # 305, Glendale, California CA 91205 or by phoning (818) 241-0220. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Charchian Medical Corp |
| Contact Person: | Nora Aghkani, Office Manager |
| Address: | 1030 South Glendale Avenue # 305, Glendale, California 91205 |
| Phone Number: | (818) 241-0220 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1985 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Chiropractors |
| SIC Code: | 8041 |
| NAICS Code: | 6211110 |
| Share This Business: |
Charchian Medical Corp was started in 1985 to provide professional Chiropractors under the SIC code 8041 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Nora Aghkani, Office Manager for inquiries that concern Charchian Medical Corp by calling the company number (818) 241-0220, as your correspondence is most welcome. Additionally, the physical location of the single location of Charchian Medical Corp can be found at the coordinates 34.134429,-118.25171 as well as the street address 1030 South Glendale Avenue # 305 in Glendale, California 91205.
For its online presence, you may visit Charchian Medical Corp’s website at and engage with its social media outlets through on Twitter and on Facebook.